4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000030
President and CEO sold 35,000 shares at an average $125.24 ($4,383,460)
From the SEC's structured data for this filing
Trades in this filing
Luly Jay R. · President and CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-07-05 | Sale : show line 1 in the form | −2,977 | $123.81 | $368,568 | 625,049 | D |
| 2018-07-06 | Sale : show line 2 in the form | −12,622 | $124.26 | $1,568,460 | 612,427 | D |
| 2018-07-06 | Sale : show line 3 in the form | −7,538 | $125.27 | $944,265 | 604,889 | D |
| 2018-07-06 | Sale : show line 4 in the form | −7,738 | $126.36 | $977,788 | 597,151 | D |
| 2018-07-06 | Sale : show line 5 in the form | −4,125 | $127.12 | $524,379 | 593,026 | D |
| Open-market sales · 35,000 sh · avg $125.24 · $4,383,460 | ||||||
Loading xslF345X03/edgar.xml…